Abstract |
Malignant pleural mesothelioma (MPM) has extremely limited treatment despite a poor prognosis. Moreover, molecular targeted therapy for MPM has not yet been implemented; thus, a new targeted therapy is highly desirable. Near-infrared photoimmunotherapy (NIR-PIT) is a recently developed cancer therapy that combines the specificity of antibodies for targeting tumors with toxicity induced by the photoabsorber after exposure to NIR-light. In this study, we developed a new phototherapy targeting podoplanin (PDPN) for MPM with the use of both NIR-PIT and an anti-PDPN antibody, NZ-1. An antibody- photosensitizer conjugate consisting of NZ-1 and phthalocyanine dye was synthesized. In vitro NIR-PIT-induced cytotoxicity was measured with both dead cell staining and luciferase activity on various MPM cell lines. In vivo NIR-PIT was examined in both the flank tumor and orthotopic mouse model with in vivo real-time imaging. In vitro NIR-PIT-induced cytotoxicity was NIR-light dose dependent. In vivo NIR-PIT led to significant reduction in both tumor volume and luciferase activity in a flank model (p < 0.05, NIR-PIT group versus NZ-1-IR700 group). The PDPN-targeted NIR-PIT resulted in a significant antitumor effect in an MPM orthotopic mouse model (p < 0.05, NIR-PIT group versus NZ-1-IR700 group). This study suggests that PDPN-targeted NIR-PIT could be a new promising treatment for MPM.
|
Authors | Yuko Nishinaga, Kazuhide Sato, Hirotoshi Yasui, Shunichi Taki, Kazuomi Takahashi, Misae Shimizu, Rena Endo, Chiaki Koike, Noriko Kuramoto, Shota Nakamura, Takayuki Fukui, Hiroshi Yukawa, Yoshinobu Baba, Mika K Kaneko, Toyofumi F Chen-Yoshikawa, Hisataka Kobayashi, Yukinari Kato, Yoshinori Hasegawa |
Journal | Cells
(Cells)
Vol. 9
Issue 4
(04 20 2020)
ISSN: 2073-4409 [Electronic] Switzerland |
PMID | 32326079
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Gp38 protein, mouse
- Immunoconjugates
- Membrane Glycoproteins
- PDPN protein, human
|
Topics |
- Animals
- Cell Line, Tumor
- Humans
- Immunoconjugates
(pharmacology)
- Immunotherapy
(methods)
- Lung Neoplasms
(drug therapy, immunology)
- Membrane Glycoproteins
(drug effects)
- Mesothelioma, Malignant
(drug therapy, immunology, pathology)
- Mice, Nude
- Molecular Targeted Therapy
- Phototherapy
(methods)
- Xenograft Model Antitumor Assays
(methods)
|